20 results
PRE 14A
RVNC
Revance Therapeutics Inc
12 Mar 21
Preliminary proxy
4:13pm
committee financial expert” within the meaning of the SEC regulations. Our Board has determined that the composition of our Audit Committee meets
10-K
aeq3skg cv4
28 Mar 14
Annual report
12:00am
424B4
g7863lizts
6 Feb 14
Prospectus supplement with pricing info
12:00am
S-1
b81o5 waknn
31 Dec 13
IPO registration
12:00am
S-1
EX-10.12
48l6 g2kfks
31 Dec 13
IPO registration
12:00am
DRS
EX-10.12
p3y58g38 izxj1
19 Apr 13
Draft registration statement
12:00am
DRS
zae65a3
19 Apr 13
Draft registration statement
12:00am
- Prev
- 1
- Next